Back
Diebold Nixdorf 10K Form
Sell
42
DBD
Diebold Nixdorf
Last Price:
$43.51
Seasonality Move:
22.4%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DBD News And Ratings
See the #1 stock for the next 7 days that we like better than DBD
DBD Financial Statistics
Sales & Book Value
| Annual Sales: | $3.8B |
|---|---|
| Cash Flow: | $186.2M |
| Price / Cash Flow: | 15.17 |
| Annual Sales: | $24.74 |
| Price / Book: | 1.78 |
Profitability
| EPS (TTM): | -0.44000 |
|---|---|
| Net Income (TTM): | $-16.5M |
| Gross Margin: | $920M |
| Return on Equity: | -1.61% |
| Return on Assets: | -0.43% |
Diebold Nixdorf Earnings Forecast
Key Diebold Nixdorf Financial Ratios
-
The Gross Profit Margin over the past 40 years for DBD is 24.53%.
-
The Selling, General & Administrative Expenses for DBD have been equal to 17.16% of Gross Profit Margin.
-
The Research & Development expenses have been 2.50% of Revenue.
-
The Net Earning history of DBD is -0.44% of Total Revenues.
-
Per Share Earnings over the last 40 years have been positive in 20 years.
Diebold Nixdorf Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Technology Hardware, Storage & Peripherals |
| Sector: | Information Technology |
| Current Symbol: | DBD |
| CUSIP: | 253651 |
| Website: | dieboldnixdorf.com |
Debt
| Debt-to-Equity Ratio: | 1 |
|---|---|
| Current Ratio: | 1.32 |
| Quick Ratio: | 0.71 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 8.87 |
DBD Technical Analysis vs Fundamental Analysis
Sell
42
Diebold Nixdorf (DBD)
is a Sell
Is Diebold Nixdorf a Buy or a Sell?
-
Diebold Nixdorf stock is rated a SellThe current Diebold Nixdorf [DBD] share price is $43.88. The Score for DBD is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.